BAT quits nicotine inhaler to focus on vaping
British American Tobacco (BAT) has quit plans to market a nicotine inhaler called Voke to focus on consumer
January 5, 2017
BAT quits nicotine inhaler to focus on vaping
British American Tobacco (BAT) has quit plans to market a nicotine inhaler called Voke to focus on consumer
January 5, 2017
Trump presses Democrats on Obamacare, calls for bipartisan fix
U.S. Republican President-elect Donald Trump on Thursday kept up his attacks on Democrats and Obamacare while calling for
January 5, 2017
Trump presses Democrats on Obamacare, calls for bipartisan fix
U.S. Republican President-elect Donald Trump on Thursday kept up his attacks on Democrats and Obamacare while calling for
January 5, 2017
Otonomy’s ear infection drug succeeds in late-stage trial
(Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection
January 5, 2017
Duck cull in France’s foie gras region to contain bird flu
French authorities have started slaughtering ducks in the main foie gras-producing region to try to contain a dangerous form
January 5, 2017
Duck cull in France’s foie gras region to contain bird flu
French authorities have started slaughtering ducks in the main foie gras-producing region to try to contain a dangerous form
January 5, 2017
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) - Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and
January 5, 2017
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) - Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and
January 5, 2017
Synthetic Biologics’ C. difficile mid-stage study meets main goal
(Reuters) - Synthetic Biologics Inc said on Thursday its experimental product designed to reduce antibiotic-resistant infections outperformed a placebo
January 5, 2017